APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calcitonin Gene Related Peptide Type 1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Calcitonin Gene Related Peptide Type 1 Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchCalcitonin Gene Related Peptide Type 1 Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Calcitonin Gene Related Peptide Type 1 Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Calcitonin Gene Related Peptide Type 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calcitonin Gene Related Peptide Type 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Calcitonin Gene Related Peptide Type 1 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Calcitonin Gene Related Peptide Type 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Calcitonin Gene Related Peptide Type 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Calcitonin Gene Related Peptide Type 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Calcitonin Gene Related Peptide Type 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Calcitonin Gene Related Peptide Type 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Calcitonin Gene Related Peptide Type 1 include Teva Pharmaceutical Industries Ltd, Eli Lilly and Company, Amgen Inc, Vertex Pharmaceuticals Inc, Merck & Co Inc, Fortress Biotech Inc, Biohaven Pharmaceutical Holding Company Ltd and Allergan Plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Calcitonin Gene Related Peptide Type 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Calcitonin Gene Related Peptide Type 1, also provides the sales of main regions and countries. Of the upcoming market potential for Calcitonin Gene Related Peptide Type 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Calcitonin Gene Related Peptide Type 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Calcitonin Gene Related Peptide Type 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Calcitonin Gene Related Peptide Type 1 sales, projected growth trends, production technology, application and end-user industry.

Calcitonin Gene Related Peptide Type 1 Segment by Company

Teva Pharmaceutical Industries Ltd

Eli Lilly and Company

Amgen Inc

Vertex Pharmaceuticals Inc

Merck & Co Inc

Fortress Biotech Inc

Biohaven Pharmaceutical Holding Company Ltd

Allergan Plc

Calcitonin Gene Related Peptide Type 1 Segment by Type

Erenumab

CGRP

AGN-241689

AFAP-3

Others

Calcitonin Gene Related Peptide Type 1 Segment by Application

Dental Pain

Cardiovascular

Metabolic Disorders

Others

Calcitonin Gene Related Peptide Type 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcitonin Gene Related Peptide Type 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calcitonin Gene Related Peptide Type 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcitonin Gene Related Peptide Type 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Calcitonin Gene Related Peptide Type 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Calcitonin Gene Related Peptide Type 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calcitonin Gene Related Peptide Type 1 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Calcitonin Gene Related Peptide Type 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Erenumab Major Manufacturers Table 3. CGRP Major Manufacturers Table 4. AGN-241689 Major Manufacturers Table 5. AFAP-3 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Calcitonin Gene Related Peptide Type 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Dental Pain Major Manufacturers Table 9. Cardiovascular Major Manufacturers Table 10. Metabolic Disorders Major Manufacturers Table 11. Others Major Manufacturers Table 12. Calcitonin Gene Related Peptide Type 1 Industry Trends Table 13. Calcitonin Gene Related Peptide Type 1 Industry Drivers Table 14. Calcitonin Gene Related Peptide Type 1 Industry Opportunities and Challenges Table 15. Calcitonin Gene Related Peptide Type 1 Industry Restraints Table 16. Global Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Calcitonin Gene Related Peptide Type 1 Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Calcitonin Gene Related Peptide Type 1 Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Region (2021-2026) Table 20. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Region (2027-2032) Table 21. Global Calcitonin Gene Related Peptide Type 1 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Calcitonin Gene Related Peptide Type 1 Sales by Region (2021-2026) & (k units) Table 23. Global Calcitonin Gene Related Peptide Type 1 Sales by Region (2027-2032) & (k units) Table 24. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Region (2021-2026) Table 25. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Region (2027-2032) Table 26. Global Calcitonin Gene Related Peptide Type 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Calcitonin Gene Related Peptide Type 1 Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Manufacturers (2021-2026) Table 30. Global Calcitonin Gene Related Peptide Type 1 Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Calcitonin Gene Related Peptide Type 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Calcitonin Gene Related Peptide Type 1 Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Calcitonin Gene Related Peptide Type 1 Manufacturers, Product Type & Application Table 34. Global Calcitonin Gene Related Peptide Type 1 Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Calcitonin Gene Related Peptide Type 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Calcitonin Gene Related Peptide Type 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Type (2021-2026) Table 41. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Type (2027-2032) Table 42. Global Calcitonin Gene Related Peptide Type 1 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 44. Global Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 45. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Type (2021-2026) Table 46. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Type (2027-2032) Table 47. Global Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2026) & (US$/unit) Table 48. Global Calcitonin Gene Related Peptide Type 1 Price by Type (2027-2032) & (US$/unit) Table 49. Global Calcitonin Gene Related Peptide Type 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Application (2021-2026) Table 53. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Application (2027-2032) Table 54. Global Calcitonin Gene Related Peptide Type 1 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 56. Global Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 57. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Application (2021-2026) Table 58. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Application (2027-2032) Table 59. Global Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2026) & (US$/unit) Table 60. Global Calcitonin Gene Related Peptide Type 1 Price by Application (2027-2032) & (US$/unit) Table 61. Teva Pharmaceutical Industries Ltd Company Information Table 62. Teva Pharmaceutical Industries Ltd Business Overview Table 63. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 65. Teva Pharmaceutical Industries Ltd Recent Development Table 66. Eli Lilly and Company Company Information Table 67. Eli Lilly and Company Business Overview Table 68. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 70. Eli Lilly and Company Recent Development Table 71. Amgen Inc Company Information Table 72. Amgen Inc Business Overview Table 73. Amgen Inc Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Amgen Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 75. Amgen Inc Recent Development Table 76. Vertex Pharmaceuticals Inc Company Information Table 77. Vertex Pharmaceuticals Inc Business Overview Table 78. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 80. Vertex Pharmaceuticals Inc Recent Development Table 81. Merck & Co Inc Company Information Table 82. Merck & Co Inc Business Overview Table 83. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 85. Merck & Co Inc Recent Development Table 86. Fortress Biotech Inc Company Information Table 87. Fortress Biotech Inc Business Overview Table 88. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 90. Fortress Biotech Inc Recent Development Table 91. Biohaven Pharmaceutical Holding Company Ltd Company Information Table 92. Biohaven Pharmaceutical Holding Company Ltd Business Overview Table 93. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 95. Biohaven Pharmaceutical Holding Company Ltd Recent Development Table 96. Allergan Plc Company Information Table 97. Allergan Plc Business Overview Table 98. Allergan Plc Calcitonin Gene Related Peptide Type 1 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Allergan Plc Calcitonin Gene Related Peptide Type 1 Product Portfolio Table 100. Allergan Plc Recent Development Table 101. North America Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 104. North America Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 105. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 110. North America Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 111. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Calcitonin Gene Related Peptide Type 1 Sales by Country (2021-2026) & (k units) Table 118. North America Calcitonin Gene Related Peptide Type 1 Sales by Country (2027-2032) & (k units) Table 119. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 122. Canada Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 123. Mexico Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 124. Europe Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 127. Europe Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 128. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 133. Europe Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 134. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Calcitonin Gene Related Peptide Type 1 Sales by Country (2021-2026) & (k units) Table 141. Europe Calcitonin Gene Related Peptide Type 1 Sales by Country (2027-2032) & (k units) Table 142. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 145. France Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 146. U.K. Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 147. Italy Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 148. Russia Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 149. Spain Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 152. Sweden Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 153. Poland Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 154. China Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 155. China Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 156. China Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 157. China Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 158. China Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 161. China Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 162. China Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 163. China Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 164. China Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 169. Asia Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 170. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 175. Asia Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 176. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Calcitonin Gene Related Peptide Type 1 Sales by Country (2021-2026) & (k units) Table 183. Asia Calcitonin Gene Related Peptide Type 1 Sales by Country (2027-2032) & (k units) Table 184. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 187. South Korea Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 188. India Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 189. Australia Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2026) & (k units) Table 195. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Type (2027-2032) & (k units) Table 196. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2026) & (k units) Table 201. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Application (2027-2032) & (k units) Table 202. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Country (2021-2026) & (k units) Table 209. SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Country (2027-2032) & (k units) Table 210. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 213. Argentina Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 214. Chile Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 215. Colombia Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 216. Peru Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 218. Israel Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 219. UAE Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 220. Turkey Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 221. Iran Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 222. Egypt Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Calcitonin Gene Related Peptide Type 1 Distributors List Table 226. Calcitonin Gene Related Peptide Type 1 Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Calcitonin Gene Related Peptide Type 1 Image Figure 2. Global Calcitonin Gene Related Peptide Type 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calcitonin Gene Related Peptide Type 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Erenumab Image Figure 5. CGRP Image Figure 6. AGN-241689 Image Figure 7. AFAP-3 Image Figure 8. Others Image Figure 9. Global Calcitonin Gene Related Peptide Type 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Calcitonin Gene Related Peptide Type 1 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Dental Pain Image Figure 12. Cardiovascular Image Figure 13. Metabolic Disorders Image Figure 14. Others Image Figure 15. Global Calcitonin Gene Related Peptide Type 1 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Calcitonin Gene Related Peptide Type 1 Revenue (2021-2032) & (US$ Million) Figure 17. Global Calcitonin Gene Related Peptide Type 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Region (2021-2032) Figure 20. Global Calcitonin Gene Related Peptide Type 1 Sales (2021-2032) & (k units) Figure 21. Global Calcitonin Gene Related Peptide Type 1 Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Calcitonin Gene Related Peptide Type 1 Sales YoY (2021-2032) & (k units) Figure 24. Europe Calcitonin Gene Related Peptide Type 1 Sales YoY (2021-2032) & (k units) Figure 25. China Calcitonin Gene Related Peptide Type 1 Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Calcitonin Gene Related Peptide Type 1 Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Calcitonin Gene Related Peptide Type 1 Sales YoY (2021-2032) & (k units) Figure 28. Global Calcitonin Gene Related Peptide Type 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Calcitonin Gene Related Peptide Type 1 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Type (2021-2032) Figure 34. Global Calcitonin Gene Related Peptide Type 1 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Type (2021-2032) Figure 37. Global Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Application (2021-2032) Figure 40. Global Calcitonin Gene Related Peptide Type 1 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Application (2021-2032) Figure 43. North America Calcitonin Gene Related Peptide Type 1 Revenue Share by Type (2021-2032) Figure 44. North America Calcitonin Gene Related Peptide Type 1 Sales Share by Type (2021-2032) Figure 45. North America Calcitonin Gene Related Peptide Type 1 Revenue Share by Application (2021-2032) Figure 46. North America Calcitonin Gene Related Peptide Type 1 Sales Share by Application (2021-2032) Figure 47. North America Calcitonin Gene Related Peptide Type 1 Revenue Share by Country (2021-2032) Figure 48. North America Calcitonin Gene Related Peptide Type 1 Sales Share by Country (2021-2032) Figure 49. Europe Calcitonin Gene Related Peptide Type 1 Revenue Share by Type (2021-2032) Figure 50. Europe Calcitonin Gene Related Peptide Type 1 Sales Share by Type (2021-2032) Figure 51. Europe Calcitonin Gene Related Peptide Type 1 Revenue Share by Application (2021-2032) Figure 52. Europe Calcitonin Gene Related Peptide Type 1 Sales Share by Application (2021-2032) Figure 53. Europe Calcitonin Gene Related Peptide Type 1 Revenue Share by Country (2021-2032) Figure 54. Europe Calcitonin Gene Related Peptide Type 1 Sales Share by Country (2021-2032) Figure 55. China Calcitonin Gene Related Peptide Type 1 Revenue Share by Type (2021-2032) Figure 56. China Calcitonin Gene Related Peptide Type 1 Sales Share by Type (2021-2032) Figure 57. China Calcitonin Gene Related Peptide Type 1 Revenue Share by Application (2021-2032) Figure 58. China Calcitonin Gene Related Peptide Type 1 Sales Share by Application (2021-2032) Figure 59. Asia Calcitonin Gene Related Peptide Type 1 Revenue Share by Type (2021-2032) Figure 60. Asia Calcitonin Gene Related Peptide Type 1 Sales Share by Type (2021-2032) Figure 61. Asia Calcitonin Gene Related Peptide Type 1 Revenue Share by Application (2021-2032) Figure 62. Asia Calcitonin Gene Related Peptide Type 1 Sales Share by Application (2021-2032) Figure 63. Asia Calcitonin Gene Related Peptide Type 1 Revenue Share by Country (2021-2032) Figure 64. Asia Calcitonin Gene Related Peptide Type 1 Sales Share by Country (2021-2032) Figure 65. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Share by Type (2021-2032) Figure 66. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Share by Type (2021-2032) Figure 67. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Share by Application (2021-2032) Figure 68. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Share by Application (2021-2032) Figure 69. SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Share by Country (2021-2032) Figure 70. SAMEA Calcitonin Gene Related Peptide Type 1 Sales Share by Country (2021-2032) Figure 71. Calcitonin Gene Related Peptide Type 1 Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Calcitonin Gene Related Peptide Type 1 Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Erenumab
  • CGRP
  • AGN-241689
  • AFAP-3
  • Others
Applications
  • Dental Pain
  • Cardiovascular
  • Metabolic Disorders
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Eli Lilly and Company
  • Amgen Inc
  • Vertex Pharmaceuticals Inc
  • Merck & Co Inc
  • Fortress Biotech Inc
  • Biohaven Pharmaceutical Holding Company Ltd
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Calcitonin Gene Related Peptide Type 1 Market by Type
  3. 1.2.1 Global Calcitonin Gene Related Peptide Type 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Erenumab
  5. 1.2.3 CGRP
  6. 1.2.4 AGN-241689
  7. 1.2.5 AFAP-3
  8. 1.2.6 Others
  9. 1.3 Calcitonin Gene Related Peptide Type 1 Market by Application
  10. 1.3.1 Global Calcitonin Gene Related Peptide Type 1 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Dental Pain
  12. 1.3.3 Cardiovascular
  13. 1.3.4 Metabolic Disorders
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Calcitonin Gene Related Peptide Type 1 Market Dynamics
  1. 2.1 Calcitonin Gene Related Peptide Type 1 Industry Trends
  2. 2.2 Calcitonin Gene Related Peptide Type 1 Industry Drivers
  3. 2.3 Calcitonin Gene Related Peptide Type 1 Industry Opportunities and Challenges
  4. 2.4 Calcitonin Gene Related Peptide Type 1 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Calcitonin Gene Related Peptide Type 1 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Calcitonin Gene Related Peptide Type 1 Revenue by Region
  3. 3.2.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Calcitonin Gene Related Peptide Type 1 Revenue by Region (2021-2026)
  5. 3.2.3 Global Calcitonin Gene Related Peptide Type 1 Revenue by Region (2027-2032)
  6. 3.2.4 Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Calcitonin Gene Related Peptide Type 1 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Calcitonin Gene Related Peptide Type 1 Sales by Region
  9. 3.4.1 Global Calcitonin Gene Related Peptide Type 1 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Region (2021-2026)
  11. 3.4.3 Global Calcitonin Gene Related Peptide Type 1 Sales by Region (2027-2032)
  12. 3.4.4 Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Manufacturers
  2. 4.1.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Calcitonin Gene Related Peptide Type 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Manufacturers
  6. 4.2.1 Global Calcitonin Gene Related Peptide Type 1 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Calcitonin Gene Related Peptide Type 1 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Calcitonin Gene Related Peptide Type 1 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Calcitonin Gene Related Peptide Type 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Calcitonin Gene Related Peptide Type 1 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Calcitonin Gene Related Peptide Type 1 Manufacturers, Product Type & Application
  13. 4.7 Global Calcitonin Gene Related Peptide Type 1 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Calcitonin Gene Related Peptide Type 1 Market CR5 and HHI
  16. 4.8.2 2025 Calcitonin Gene Related Peptide Type 1 Tier 1, Tier 2, and Tier 3
5 Calcitonin Gene Related Peptide Type 1 Market by Type
  1. 5.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Type
  2. 5.1.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Type
  6. 5.2.1 Global Calcitonin Gene Related Peptide Type 1 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Calcitonin Gene Related Peptide Type 1 Price by Type
6 Calcitonin Gene Related Peptide Type 1 Market by Application
  1. 6.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Application
  2. 6.1.1 Global Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Calcitonin Gene Related Peptide Type 1 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Application
  6. 6.2.1 Global Calcitonin Gene Related Peptide Type 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Calcitonin Gene Related Peptide Type 1 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Calcitonin Gene Related Peptide Type 1 Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries Ltd
  2. 7.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 7.2 Eli Lilly and Company
  8. 7.2.1 Eli Lilly and Company Company Information
  9. 7.2.2 Eli Lilly and Company Business Overview
  10. 7.2.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Product Portfolio
  12. 7.2.5 Eli Lilly and Company Recent Developments
  13. 7.3 Amgen Inc
  14. 7.3.1 Amgen Inc Company Information
  15. 7.3.2 Amgen Inc Business Overview
  16. 7.3.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio
  18. 7.3.5 Amgen Inc Recent Developments
  19. 7.4 Vertex Pharmaceuticals Inc
  20. 7.4.1 Vertex Pharmaceuticals Inc Company Information
  21. 7.4.2 Vertex Pharmaceuticals Inc Business Overview
  22. 7.4.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio
  24. 7.4.5 Vertex Pharmaceuticals Inc Recent Developments
  25. 7.5 Merck & Co Inc
  26. 7.5.1 Merck & Co Inc Company Information
  27. 7.5.2 Merck & Co Inc Business Overview
  28. 7.5.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio
  30. 7.5.5 Merck & Co Inc Recent Developments
  31. 7.6 Fortress Biotech Inc
  32. 7.6.1 Fortress Biotech Inc Company Information
  33. 7.6.2 Fortress Biotech Inc Business Overview
  34. 7.6.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Product Portfolio
  36. 7.6.5 Fortress Biotech Inc Recent Developments
  37. 7.7 Biohaven Pharmaceutical Holding Company Ltd
  38. 7.7.1 Biohaven Pharmaceutical Holding Company Ltd Company Information
  39. 7.7.2 Biohaven Pharmaceutical Holding Company Ltd Business Overview
  40. 7.7.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Product Portfolio
  42. 7.7.5 Biohaven Pharmaceutical Holding Company Ltd Recent Developments
  43. 7.8 Allergan Plc
  44. 7.8.1 Allergan Plc Company Information
  45. 7.8.2 Allergan Plc Business Overview
  46. 7.8.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Product Portfolio
  48. 7.8.5 Allergan Plc Recent Developments
8 North America
  1. 8.1 North America Calcitonin Gene Related Peptide Type 1 Market Size by Type
  2. 8.1.1 North America Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032)
  3. 8.1.2 North America Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032)
  4. 8.1.3 North America Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2032)
  5. 8.2 North America Calcitonin Gene Related Peptide Type 1 Market Size by Application
  6. 8.2.1 North America Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032)
  7. 8.2.2 North America Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032)
  8. 8.2.3 North America Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2032)
  9. 8.3 North America Calcitonin Gene Related Peptide Type 1 Market Size by Country
  10. 8.3.1 North America Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Calcitonin Gene Related Peptide Type 1 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Calcitonin Gene Related Peptide Type 1 Market Size by Type
  2. 9.1.1 Europe Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032)
  4. 9.1.3 Europe Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2032)
  5. 9.2 Europe Calcitonin Gene Related Peptide Type 1 Market Size by Application
  6. 9.2.1 Europe Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032)
  8. 9.2.3 Europe Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2032)
  9. 9.3 Europe Calcitonin Gene Related Peptide Type 1 Market Size by Country
  10. 9.3.1 Europe Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Calcitonin Gene Related Peptide Type 1 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Calcitonin Gene Related Peptide Type 1 Market Size by Type
  2. 10.1.1 China Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032)
  3. 10.1.2 China Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032)
  4. 10.1.3 China Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2032)
  5. 10.2 China Calcitonin Gene Related Peptide Type 1 Market Size by Application
  6. 10.2.1 China Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032)
  7. 10.2.2 China Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032)
  8. 10.2.3 China Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Calcitonin Gene Related Peptide Type 1 Market Size by Type
  2. 11.1.1 Asia Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032)
  4. 11.1.3 Asia Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2032)
  5. 11.2 Asia Calcitonin Gene Related Peptide Type 1 Market Size by Application
  6. 11.2.1 Asia Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032)
  8. 11.2.3 Asia Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2032)
  9. 11.3 Asia Calcitonin Gene Related Peptide Type 1 Market Size by Country
  10. 11.3.1 Asia Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Calcitonin Gene Related Peptide Type 1 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Calcitonin Gene Related Peptide Type 1 Market Size by Type
  2. 12.1.1 SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Calcitonin Gene Related Peptide Type 1 Price by Type (2021-2032)
  5. 12.2 SAMEA Calcitonin Gene Related Peptide Type 1 Market Size by Application
  6. 12.2.1 SAMEA Calcitonin Gene Related Peptide Type 1 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Calcitonin Gene Related Peptide Type 1 Price by Application (2021-2032)
  9. 12.3 SAMEA Calcitonin Gene Related Peptide Type 1 Market Size by Country
  10. 12.3.1 SAMEA Calcitonin Gene Related Peptide Type 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Calcitonin Gene Related Peptide Type 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Calcitonin Gene Related Peptide Type 1 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Calcitonin Gene Related Peptide Type 1 Value Chain Analysis
  2. 13.1.1 Calcitonin Gene Related Peptide Type 1 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Calcitonin Gene Related Peptide Type 1 Production Mode & Process
  6. 13.2 Calcitonin Gene Related Peptide Type 1 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Calcitonin Gene Related Peptide Type 1 Distributors
  9. 13.2.3 Calcitonin Gene Related Peptide Type 1 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst